Reshaping Lives: Full Circle
will provide post-mastectomy reconstructive breast surgery to women in need of assistance
SANTA BARBARA, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) —
Sientra, Inc.
, a medical aesthetics company uniquely focused on plastic surgery, and
Mission Plasticos
, a 501-c3 non-profit organization dedicated to providing reconstructive surgical care to those in medically underserved communities around the globe, today announced the launch of
Reshaping Lives: Full Circle
, a nationwide program aimed at providing reconstructive breast surgery for post-mastectomy women living in poverty. This is the first phase of Mission Plasticos’ recently announced
Reshaping Lives America
, the first large-scale, nationwide program providing reconstructive surgical care at no cost to people living in poverty in the U.S., and is being funded through a $1 million donation from Sientra.
“Sientra has a rich history of giving back to the community, starting with our Full Circle grant program and now continuing through our support of Mission Plasticos’, Reshaping Lives: America initiative,” said Ron Menezes, President and CEO of Sientra and Chairman of the Reshaping Lives America Corporate Council. “With this partnership, we are pleased to expand and amplify our Full Circle program, which will now become
Reshaping Lives: Full Circle
. This new program will provide women in need with access to breast recontruction and allow Sientra to make a significant impact to the reconstruction community in a targeted way.”
Sientra will recruit board-certified volunteer surgeons across the United States to join the program and will provide their state-of-the-art silicone gel breast implants, which have an unrivaled safety profile and are clinically shown to have low complication rates
1
; and their one-of-a-kind breast tissue expanders, which are used to form a new breast pocket that will eventually hold the long-term breast implant, at no cost for qualified women enrolled in the program. Mission Plasticos will then pair those surgeons with appropriate local patients, at no cost to the patient.
“At Mission Plasticos, we are driven by the belief that all women deserve a full journey of care, regardless of their economic situation, and we are excited to partner with a company that also shares this belief,” said Susan Williamson, Executive Director of Mission Plasticos. “Thanks to Sientra’s generous $1M donation and commitment, together we can focus on closing the gaps in care for women with cancer living in poverty.”
According to one study in 2017 that examined the influence of health insurance coverage on the use of immediate breast reconstruction in working-age women with breast cancer, breast reconstruction among women with private insurance was more than 3 times greater than among women on Medicaid
2
, and other barriers to obtaining the procedure include rural location, more severe breast cancer, and greater age
3
. The
Reshaping Lives: Full Circle
, initiative aims to help women in America experiencing these barriers to access a full journey of care. For more information, please visit
www.ReshapingLivesFullCircle.org
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s product portfolio includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2
®
breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM
®
, the #1 performing, preferred and recommended scar gel of plastic surgeons(*).
Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at
www.sientra.com
.
(*)
Data on file
1.
Stevens WG, Calobrace MB, Alizadeh A, Zeidler KR, Harrington JL, d’Incelli RC. Ten-year core study data for Sientra’s Food and Drug Administration—approved round and shaped breast implants with cohesive silicone gel. Plast Reconstr Surg. 2018;141(4S):7S-19S
2.
Pasalic D, Jiang J, Jagsi R, Giordano SH, Smith BD. Association of Insurance Status with the Use of Immediate Breast Reconstruction in Women with Breast Cancer. Plast Reconstr Surg Glob Open. 2017;5(7):e1360. Published 2017 Jul 26. doi:10.1097/GOX.0000000000001360
3
Siotos C, Lagiou P, Cheah MA, et al. Determinants of receiving immediate breast reconstruction: An analysis of patient characteristics at a tertiary care center in the US. Surg Oncol. 2020;34:1-6. doi:10.1016/j.suronc.2020.02.017
Sientra Contact:
Media
EvolveMKD
[email protected]
About Mission Plasticos
Mission Plasticos, a 501-c3 non-profit organization, is dedicated to providing reconstructive surgery to those in need, training local medical professionals, and supporting ongoing research focused on improving standards of care. Our board-certified volunteer surgeons and medical teams provide reconstructive breast surgery for post-mastectomy women, burn contracture surgery, and other reconstructive surgical care at no cost to patients. Over the last two decades, Mission Plasticos has completed more than 90 missions in 15 countries, trained over 5,000 doctors, and treated over 15,000 patients. Its highly acclaimed Reshaping Lives California program is being expanded nationally to serve medically underserved patients in the U.S. through its Reshaping Lives America program. For more information, visit
.
Mission Plasticos Contact:
Media
Brittany Rayburn
TogoRun
[email protected]
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, based on management’s current assumptions and expectations of future events and trends, which affect or may affect the Company’s business, strategy, operations or financial performance, and actual results may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are made only as of the date of this release. The words ‘‘believe,’’ ‘‘may,’’ ‘‘might,’’ ‘‘could,’’ ‘‘will,’’ ‘‘aim,’’ ‘‘estimate,’’ ‘‘continue, ‘‘anticipate,’’ ‘‘intend,’’ ‘‘expect,’’ ‘‘plan,’’ ‘‘position,” or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes are intended to identify estimates, projections and other forward-looking statements. Forward-looking statements may include information concerning the Company’s impact on the reconstruction community, the Company’s ability to close the gaps in care for woman living with cancer in poverty, the Company’s ability to recruit board-certified plastic surgeons, and the positive reactions from plastic surgeons to Sientra’s products and the Reshaping Lives: Full Circle. Additional factors that could cause actual results to differ materially from those contemplated in this press release can be found in the Risk Factors section of Sientra’s public filings with the Securities and Exchange Commission. All statements other than statements of historical fact are forward-looking statements. The words ‘‘believe,’’ ‘‘may,’’ ‘‘might,’’ ‘‘could,’’ ‘‘will,’’ ‘‘aim,’’ ‘‘estimate,’’ ‘‘continue, ‘‘anticipate,’’ ‘‘intend,’’ ‘‘expect,’’ ‘‘plan,’’ ‘‘position,” or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes are intended to identify estimates, projections and other forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, and such estimates, projections and other forward-looking statements speak only as of the date they were made, and, except to the extent required by law, the Company undertakes no obligation to update or review any estimate, projection or forward-looking statement. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in the Company’s business.
